LUMINATE 102: A real-world study on biomarker testing rates among patients with non-small cell lung cancer (NSCLC) across lines of therapy

2023

Aggarwal C, Xu Q, Ng S, Kamalakar R, Crawford S, Beruti S, Myftiu A, Beasley MB